Supreme Court Might Review Whistle-Blower Case That Could Set Limits On Lawsuits Against Drugmakers, Biotech Firms

The U.S. Supreme Court is considering reviewing a case that could set new limits on whistle-blower lawsuits against drugmakers, biotechnology companies and other businesses, Bloomberg reports. The court has asked the Department of Justice for advice on the suit, which alleges that a North Carolina water district fraudulently sought federal money for storm cleanup. The case is based on the U.S.

More: continued here

Filed under: Medical Malpractice / Litigation on December 11th, 2008